Sarah Clark

Dr. Sarah Clark

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
TSTaylor K. Soderborg
Taylor K. Soderborg
SCSarah Clark
Sarah Clark
CMChristopher E. Mulligan
Christopher E. Mulligan
RJRachel C. Janssen
Rachel C. Janssen
LBLyndsey Babcock
Lyndsey Babcock
Jacob FriedmanJacob Friedman
Jacob Friedman
Maternal obesity is associated with increased risk for offspring obesity and non-alcoholic fatty liver disease (NAFLD), but the causal drivers of this association are unclear. Early colonization of the infant gut by microbes plays a critical role in establishing immunity and metabolic function. Here, we compare germ-free mice colonized with stool microbes (MB) from 2-week-old infants born to obese (Inf-ObMB) or normal-weight (Inf-NWMB) mothers. Inf-ObMB-colonized mice demonstrate increased hepatic gene expression for endoplasmic reticulum stress and innate immunity together with histological signs of periportal inflammation, a histological pattern more commonly reported in pediatric cases of NAFLD. Inf-ObMB mice show increased intestinal permeability, reduced macrophage phagocytosis, and dampened cytokine production suggestive of impaired macrophage function. Furthermore, exposure to a Western-style diet in Inf-ObMB mice promotes excess weight gain and accelerates NAFLD. Overall, these results provide functional evidence supporting a causative role of maternal obesity-associated infant dysbiosis in childhood obesity and NAFLD.

28 March 2008 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
DMDouglas McIntosh
Douglas McIntosh
MCMichelle Cunningham
Michelle Cunningham
BJBaijing Ji
Baijing Ji
FFFrank A. Fekete
Frank A. Fekete
EPErin M. Parry
Erin M. Parry
RRRachael Ritchie
Rachael Ritchie
The aim of this study was to examine the molecular basis for multiple antibiotic and mercury resistance in Canadian isolates of Aeromonas salmonicida subsp. salmonicida. Phenotypic and genotypic methods were employed to identify plasmid-associated antibiotic and mercury resistance genes and to determine the organization of those genes in multidrug-resistant (MDR) A. salmonicida isolates. The MDR phenotype was transferable via conjugation using Escherichia coli, Aeromonas hydrophila and Edwardseilla tarda as recipients. Antibiotic and mercury resistance genes were carried by a conjugative IncA/C plasmid. Three distinct antibiotic resistance cassettes were characterized; first a class I integron containing an aadA7 gene encoding for an aminoglycoside-3′-adenyltransferase, the second cassette showed 99.9% nucleotide sequence homology to a cassette previously identified in the Salmonellaenterica IncA/C plasmid pSN254, containing floR, tetA, sulII and strA/strB sequences. The third cassette showed 100% nucleotide sequence similarity to a transposon-like element, containing a blaCMY-2 β-lactamase in association with sugE and blc sequences. This element is known to be widely distributed among clinical and food-borne Salmonella and other Enterobacteriaceae throughout Asia and the United States. Mercury resistance was linked to the presence of a mer operon that showed 100% nucleotide sequence homology to the mer operon carried by plasmid pSN254. Each MDR A. salmonicida isolate carried the same plasmid, which was related to plasmid pSN254. This is the first report of plasmid-mediated florfenicol-resistant A. salmonicida in North America. In addition, it is the first report of a plasmid-associated AmpC β-lactamase sequence in a member of the Aeromonadaceae.

9 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KHKadi J. Horn
Kadi J. Horn
MSMelissa A. Schopper
Melissa A. Schopper
ZDZoe G. Drigot
Zoe G. Drigot
SCSarah Clark
Sarah Clark
This study investigates how specific members of the lung microbiome influence the early immune response to infection. Prevotella species are a major component of the endogenous airway microbiota. Increased abundance of Prevotella melaninogenica correlates with reduced infection with the bacterial pathogen Streptococcus pneumoniae, indicating a potentially beneficial role. Here, we show that P. melaninogenica enhances protection against S. pneumoniae, resulting in rapid pathogen clearance from the lung and improved survival in a mouse lung co-infection model. This response requires recognition of P. melaninogenica lipoproteins by toll-like receptor (TLR)2, the induction of TNFα, and neutrophils, as the loss of any of these factors abrogates Prevotella-induced protection. Improved clearance of S. pneumoniae is associated with increased serine protease-mediated killing by lung neutrophils and restraint of P. melaninogenica-induced inflammation by IL-10 in co-infected mice. Together, these findings highlight innate immune priming by airway Prevotella as an important protective feature in the respiratory tract.

1 February 2013 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
SCSarah Clark
Sarah Clark
JWJeffrey N. Weiser
Jeffrey N. Weiser
All microorganisms dependent on persistence in a host for survival rely on either hiding from or modulating host responses to infection. The small molecule phosphorylcholine, or choline phosphate (ChoP), is used for both of these purposes by a wide array of bacterial and parasitic microbes. While the mechanisms underlying ChoP acquisition and expression are diverse, a unifying theme is the use of ChoP to reduce the immune response to infection, creating an advantage for ChoP-expressing microorganisms. In this minireview, we discuss several benefits of ChoP expression during infection as well as how the immune system fights back against ChoP-expressing pathogens.

19 May 2020 in Current Opinion in Immunology
Verified
Journal Article
Closed access
SCSarah Clark
Sarah Clark

13 June 2016 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SCSarah Clark
Sarah Clark
HFHolly C Filak
Holly C Filak
BGBrandon S Guthrie
Brandon S Guthrie
RSRebecca L Schmidt
Rebecca L Schmidt
AJAmanda Jamieson
Amanda Jamieson
Laurel L. LenzLaurel L. Lenz
Laurel L. Lenz
Natural killer (NK) cells produce interferon (IFN)-γ and thus have been suggested to promote type I immunity during bacterial infections. Yet, Listeria monocytogenes (Lm) and some other pathogens encode proteins that cause increased NK cell activation. Here, we show that stimulation of NK cell activation increases susceptibility during Lm infection despite and independent from robust NK cell production of IFNγ. The increased susceptibility correlated with IL-10 production by responding NK cells. NK cells produced IL-10 as their IFNγ production waned and the Lm virulence protein p60 promoted induction of IL-10 production by mouse and human NK cells. NK cells consequently exerted regulatory effects to suppress accumulation and activation of inflammatory myeloid cells. Our results reveal new dimensions of the role played by NK cells during Lm infection and demonstrate the ability of this bacterial pathogen to exploit the induction of regulatory NK cell activity to increase host susceptibility. Natural killer (NK) cells are an innate immune cell population known to promote antiviral immunity through cytolysis and production of cytokines. Yet, some pathogens encode proteins that cause increased NK cell activation. Here, using a model of systemic infection by the bacterial pathogen Listeria monocytogenes (Lm), we show that NK cell activation increases host susceptibility. Activated NK cells increased bacterial burdens in infected tissues despite their early production of the pro-inflammatory cytokine IFNγ. We found that the ability of NK cells to exacerbate infection was independent from their production of IFNγ and instead due to subsequent production of the anti-inflammatory cytokine IL-10. A single bacterial protein, p60, was sufficient to elicit NK cell production of both early IFNγ and delayed IL-10. IL-10-production by NK cells has been shown to occur in other systems, but our studies are first to show how this “regulatory” response impacts the course of a bacterial infection. We found that IL-10 producing NK cells suppress accumulation and activation of inflammatory myeloid cells. Our studies suggest that the exploitation of NK cell regulatory activity provides selective pressure for the evolution of pathogen proteins that promote NK cell activation.